|
|
|
| Trend in incidence of thyroid cancer in Jinhua City from 2016 to 2024 |
| WANG Cheng, WANG Xiaohong, ZHOU Fan
|
| Jinhua Center for Disease Control and Prevention, Jinhua, Zhejiang 321000, China |
|
|
|
|
Abstract Objective To investigate the trend in incidence of thyroid cancer in Jinhua City, Zhejiang Province from 2016 to 2024, so as to provide a basis for optimizing prevention and control strategies for thyroid cancer. Methods Data on incidence of thyroid cancer in Jinhua City from 2016 to 2024 were collected through the Zhejiang Provincial Chronic Disease Surveillance Information Management System. The crude incidence of thyroid cancer was calculated and standardized using the data from the Sixth National Population Census in 2010. The average annual percent change (AAPC) was used to analyze the temporal trend in incidence of thyroid cancer from 2016 to 2024, and a linear regression model was employed to calculate average age of onset and analyze its trend over the same period. Results From 2016 to 2024, the crude incidence and age-standardized incidence of thyroid cancer in Jinhua City were 59.76/105 and 56.18/105, respectively, showing increasing trends (AAPC=11.447%, 12.457%, both P<0.05). The crude incidence and age-standardized incidence for males were 29.55/105 and 28.94/105, respectively, also showing increasing trends (AAPC=14.237%, 14.568%, both P<0.05). For females, the crude incidence and age-standardized incidence were 90.71/105 and 84.76/105, with significant increasing trends (AAPC=11.017%, 11.696%, both P<0.05). The crude incidence of thyroid cancer for the overall population, males, and females first increased and then decreased with advancing age, peaking at ages 40-<45 years, 40-<45 years, and 45-<50 years, with peak rates of 112.56/105, 57.51/105 and 172.29/105, respectively. From 2016 to 2024, the crude incidence of thyroid cancer showed increasing trends across all age groups from 15-<80 years (all P<0.05), whereas no statistically significant trend was observed in the ≥80 years age group (P>0.05). The average age of onset of thyroid cancer in the overall population was 47.36 years. The average age of onset for males, which was significantly lower than that for females (46.57 vs. 47.62 years, P<0.05). The average age of onset for males increased from 45.80 years in 2016 to 47.16 years in 2024, with an average annual increase of 0.23 years (P<0.05). No statistically significant trend in the average age of onset was observed for the overall population or for females (both P>0.05). Conclusion The incidence of thyroid cancer in Jinhua City showed an increasing trend from 2016 to 2024, highlighting the need to strengthen early screening and intervention for thyroid cancer among women and middle-aged populations.
|
|
Received: 01 April 2026
Revised: 06 July 2026
Published: 27 July 2026
|
|
|
|
|
|
[1] Zhang L,Jiang L L,Xu R,et al.Epidemiological study of thyroid cancer at global,regional,and national levels from 1990 to 2021:an analysis derived from the Global Burden of Disease Study 2021[J/OL].Front Endocrinol,2025,16[2026-07-06].https://doi.org/10.3389/fendo.2025.1644270.
[2] Zhai M M,Zhang D,Long J H,et al.The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories:a systematic analysis for the Global Burden of Disease Study[J].Cancer Med,2021,10(13):4542-4554.
[3] Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[4] Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countrie[J].CA Cancer J Clin,2024,74(3):229-263.
[5] 赫捷,魏文强.2021中国肿瘤登记年报[M].北京:人民卫生出版社,2023.
[6] 王裕新,潘凯枫,李文庆.2022全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2024,10(3):1-16.
[7] Lyu Z Y,Zhang Y,Sheng C,et al.Global burden of thyroid cancer in 2022:incidence and mortality estimates from GLOBOCAN[J].Chin Med J,2024,137(21):2567-2576.
[8] 项彩英,陈颖,汪德兵,等.2021年浙江省肿瘤登记地区甲状腺癌发病与死亡特征及2000—2021年变化趋势分析[J].中国肿瘤,2025,34(10):756-763.
[9] 王小红,周凡,陈梦倩,等.2016—2024年金华市恶性肿瘤发病特征及流行趋势预测[J].中国慢性病预防与控制,2026,34(5):398-401.
[10] 郭晓慧,王丽敏,王辉,等.2007—2016年天津市南开区甲状腺癌发病和死亡趋势分析[J].中国慢性病预防与控制,2021,29(11):878-881.
[11] 闫瑞平,李建彬,安戈,等.2016—2021年郑州市肿瘤登记地区甲状腺癌发病和死亡趋势分析[J].预防医学,2026,38(3):267-273.
[12] 苏幸,郑琳,章华米,等.2010—2020年浙江省杭州市西湖区甲状腺癌发病特征和流行趋势分析[J].疾病监测,2022,37(10):1367-1370.
[13] 韩亚蓉,韩颖颖,蔡波,等.2013—2022年南通市甲状腺癌发病和死亡趋势分析[J].预防医学,2026,38(1):20-25.
[14] 胡珊,庄一渝,朱炜琴,等.健康体检人群甲状腺结节检出情况及相关因素分析[J].中华保健医学杂志,2023,25(2):196-199.
[15] Lin Y T,Wu Y.Trends in incidence and overdiagnosis of thyroid cancer in China,Japan,and South Korea[J].Cancer Sci,2023,114(10):4052-4062.
[16] Han M A,Kim J H.Diagnostic X-ray exposure and thyroid cancer risk:systematic review and meta-analysis[J].Thyroid,2018,28(2):220-228.
[17] 渠宁,王钰婷,马奔,等.2022年度甲状腺癌研究及诊疗新进展[J].中国癌症杂志,2023,33(5):423-430.
[18] 李永浩,高雪菲,郭田田,等.肥胖合并甲状腺癌相关机制的研究进展[J/OL].中华普通外科学文献(电子版),2023,17(4):311-315.
[19] 胡君,周锋,姜涌斌,等.中青年甲状腺结节患者发生甲状腺癌的工作、生活行为方式影响因素[J].环境与职业医学,2024,41(2):200-206.
[20] 张亦涵,徐浣白.雌激素及其信号通路与甲状腺乳头状癌关系的研究进展[J].国际内分泌代谢杂志,2023,43(3):225-228.
[21] Fernandes-Taylor S,Bowles E J A,Venkatesh M,et al.Differential ultrasound rates mirror sex disparities in thyroid cancer[J].Thyroid,2024,34(12):1531-1539.
[22] Papaleontiou M,Norton E C,Reyes-Gastelum D,et al.Competing causes of death in older adults with thyroid cancer[J].Thyroid,2021,31(9):1359-1365.
[23] 滕勇勇,谢水仙,陈美婷,等.2010—2017年广东省珠海市甲状腺癌发病特征与趋势分析[J].河南预防医学杂志,2021,32(8):578-582.
[24] 董雯婷,王占明,宇应涛.3 750例甲状腺癌住院病例特征分析[J].中国病案,2023,24(6):73-75. |
|
|
|
